Literature DB >> 15191513

Chronic gastritis with expression of inducible nitric oxide synthase is associated with high expression of interleukin-6 and hypergastrinaemia.

H Kai1, M Ito, Y Kitadai, S Tanaka, K Haruma, K Chayama.   

Abstract

BACKGROUND AND AIMS: High levels of inducible nitric oxide synthase and nitrotyrosine in Helicobacter pylori-infected gastric mucosa may contribute to development of gastric cancer. We investigated the relation between expression of inducible nitric oxide synthase and proinflammatory cytokines in gastric mucosa and serum markers of gastritis.
METHODS: The study included 103 patients with H. pylori infection. We examined levels of interleukin-1beta, interleukin-6 and interleukin-8 by enzyme-linked immunosorbent assay and evaluated expression of inducible nitric oxide synthase and nitrotyrosine by immunohistochemical staining. Furthermore, we assessed serum levels of pepsinogens, gastrin, anti-parietal cell antibody, nitrite and nitrate, as markers of gastritis.
RESULTS: Thirty-seven of 103 (35.6%) gastric mucosa specimens showed simultaneous expression of inducible nitric oxide synthase and nitrotyrosine. In these patients (inducible nitric oxide synthase-positive group), the serum level of gastrin was significantly higher than that of the inducible nitric oxide synthase-negative group (509.5 +/- 141.5 pg/mL vs. 210.0 +/- 227.2 pg/mL; P < 0.01), whereas there were no significant differences in serum levels of pepsinogen, anti-parietal cell antibody, and nitrate and nitrite or in scores of histological gastritis. Interleukin-6 levels were significantly higher in the inducible nitric oxide synthase-positive group than in the inducible nitric oxide synthase-negative group (25.9 +/- 7.0 pg/mg protein vs. 10.6 +/- 4.9 pg/mg protein; P < 0.05).
CONCLUSIONS: Inducible nitric oxide synthase-producing gastritis was correlated with high levels of interleukin-6. Patients with hypergastrinaemia should be carefully followed on a long-term basis to ensure that the development of any malignancy is detected early.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15191513     DOI: 10.1111/j.1365-2036.2004.01965.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  5 in total

Review 1.  Helicobacter pylori infection, gastrin and cyclooxygenase-2 in gastric carcinogenesis.

Authors:  Yun Shao; Kun Sun; Wei Xu; Xiao-Lin Li; Hong Shen; Wei-Hao Sun
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 2.  Causal role of Helicobacter pylori infection and eradication therapy in gastric carcinogenesis.

Authors:  Masanori Ito; Shinji Tanaka; Tomoari Kamada; Ken Haruma; Kazuaki Chayama
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

3.  Pathogenetic role of the tyrosine-phosphorylated CagA EPIYA sequence of Helicobacter pylori in histological gastritis in Japanese patients.

Authors:  Shunsuke Takata; Masanori Ito; Yoshihiro Wada; Masaharu Yoshihara; Shinji Tanaka; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2009-04-04       Impact factor: 7.527

4.  Basis of decreased risk of gastric cancer in severe atrophic gastritis with eradication of Helicobacter pylori.

Authors:  Akira Tari; Yasuhiko Kitadai; Masaharu Sumii; Atsunori Sasaki; Hiroshi Tani; Sinji Tanaka; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2006-12-07       Impact factor: 3.487

5.  Elevated gaseous luminal nitric oxide and circulating IL-8 as features of Helicobacter pylori-induced gastric inflammation.

Authors:  Hiwa K Saaed; Lisa Chiggiato; Dominic-Luc Webb; Ann-Sofie Rehnberg; Carlos A Rubio; Ragnar Befrits; Per M Hellström
Journal:  Ups J Med Sci       Date:  2021-10-15       Impact factor: 2.384

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.